Skip to main content
Leap Therapeutics, Inc. (LPTX)
NASDAQ: LPTX · Real-Time Price · USD
3.670
-0.070 (-1.87%)
At close: Nov 4, 2024, 4:00 PM
3.490
-0.180 (-4.90%)
After-hours: Nov 4, 2024, 5:08 PM EST

Leap Therapeutics Revenue

Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
54
Market Cap
140.43M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 20211.50M--
Dec 31, 20201.50M--
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro
Dec 31, 2015 Pro Pro Pro
Dec 31, 2014 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
MultiPlan 954.92M
Puma Biotechnology 219.14M
InfuSystem Holdings 129.37M
Akoya Biosciences 93.22M
Aclaris Therapeutics 32.02M
Generation Bio Co. 13.17M
Inovio Pharmaceuticals 591.86K
Seres Therapeutics 374.00K
Revenue Rankings

LPTX News

More News